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Abstract  
Eruptive disseminated porokeratosis (EDP) is a disease clinically presenting with sudden onset 
of erythematous papules and plaques, with a ridge-like border histologically represented by a 
cornoid lamella.  We report a case of EDP occurring in a 39-year-old woman three days after 
completing a two-week course of oral corticosteroid therapy for an acute asthma exacerbation.  
Our patient was treated with emollients and sun protection.  Unlike the more chronic 
disseminated superficial (actinic) porokeratosis (DSP), EDP secondary to immunosuppression 
from corticosteroid therapy is very rarely reported in the dermatologic literature. 
Introduction 
Porokeratosis is a clonal disorder of keratinocytes characterized by annular atrophic plaques 
surrounded by ridge-like borders that expand centrifugally, with the histological feature of 
cornoid lamella, a column of parakeratotic cells.  Five clinical variants of porokeratosis have 
been described: Mibelli disease, disseminated superficial (actinic), porokeratosis palmaris et 
plantaris disseminata, linear, and punctate porokeratosis.1  Porokeratosis lesions result from the 
peripheral expansion of an abnormal mutant clone of epidermal keratinocytes, which may be 
triggered by light, trauma, infection, or immunosuppression.2  In immunosuppressed patients, it 
is usually the disseminated superficial (actinic) porokeratosis (DSP) variant that is seen, typically 
appearing on extremities symmetrically and less often the trunk.3-4 
Immunosuppression-induced DSP has been reported in the literature in the context of 
transplantation, hematological malignancy, HIV infection, electron beam irradiation, 
immunosuppressive chemotherapy and systemic corticosteroids.3  While DSP is almost always 
asymptomatic and insidious, Schena et al4 reported only sixteen worldwide cases of an acute, 
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pruritic variant of DSP known as eruptive disseminated porokeratosis (EDP).  We describe a rare 
case of EDP, only the second of which can be most attributable to corticosteroid-induced 
immunosuppression. 
Case Report 
A 39-year-old Caucasian woman presented with multiple scattered, erythematous, blanchable, 
well-defined papules and plaques with atrophic centers.  The lesions appeared suddenly on her 
lower legs, forearms, and upper chest.  Initially asymptomatic, they soon became pruritic.  She 
had signs of actinic damage including solar lentigines on her face, chest, back, and upper 
extremities; however, she denied recent sun exposure.  She also denied any personal or family 
history of previous rashes.  The patient had a past medical history of well-controlled asthma and 
treated histoplasmosis ten years prior.  She gave a history of vomiting and diarrhea of one day’s 
duration a month prior and a twenty-four pound weight loss since this episode due to lack of 
appetite.  Furthermore, she had a non-productive, persistent cough with periodic shortness of 
breath and wheezing that was not ameliorated by a week-long course of levofloxacin. 
She was treated with a prednisone taper two weeks prior to presentation for suspected asthma 
flair secondary to viral infection, after extensive work-up and rule out of active histoplasmosis, 
tuberculosis, or underlying pulmonary malignancy.  Her taper started at 60 mg daily for one 
week, reduced by 20 mg every three days thereafter.  The rash appeared three days following 
cessation of oral steroids (two days after completing levofloxacin). 
Close examination with light and magnification revealed a peripheral, keratotic rim characteristic 
of porokeratosis.  Punch biopsy obtained from representative lesions on the left leg revealed 
peripheral perifollicular dyskeratotic basal cells with cornoid lamella as well as focal absence of 
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the granular cell layer in these areas with sparse superficial perivascular lymphocytic infiltrate in 
the dermis, confirming the diagnosis of porokeratosis.  Sun protection, emollients, and 
observation for signs of malignant degeneration were discussed.  Two months later the patient 
displayed continuing improvement of the lesions, resolution of the cough with inhaled 
corticosteroids, and weight gain. 
(Insert figure 1) 
(Insert figure 2) 
(Insert figure 3) 
Discussion 
EDP is characterized by a sudden onset of small monomorphic erythematous plaques on the 
trunk, arms, and legs that are typically pruritic.  While DSP is a chronic skin disorder usually 
clinically defined by a slow onset developing over years, EDP is unique in that the disseminated 
lesions appear within a few days to months.  Schena et al4 presented this concept of EDP as a 
new variant of porokeratosis that clinically resembles DSP with lesions similarly distributed but 
with different time evolution.  EDP has previously been described in patients with cancer of the 
liver, colon, and pancreas, organ transplant, diabetes mellitus, herpes simplex infection4, bone 
marrow transplant3, myelodysplastic syndrome5, and both immunosuppressant6,7 and 
nonimmunosuppressant8,9 drug therapy.  Only one other case of EDP due directly to systemic 
corticosteroid immunosuppression, a 75-year-old man treated with betamethasone for DSP7, has 
been previously reported. 
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In concordance with EDP as a paraneoplastic syndrome4, as pulmonary malignancy was ruled 
out, the trigger for EDP in our patient was likely due to immunosuppression secondary to 
systemic corticosteroid therapy.  Also included in the differential is EDP secondary to an 
idiosyncratic drug reaction to the antibiotic she had recently taken, akin to a recent report citing a 
similar presentation suggestive of perioperative flucloxacillin and/or gentamicin causing EDP in 
a 63-year-old man.9  However, the disparity in lesion resolution time and classes of antibiotics 
used between the cases makes this less likely.   In fact, there are reports of other drugs causing 
EDP such as anti-TNF therapy6 and sumarin8 that, while not directly applicable in our patient, 
should be considered in future cases.  As our patient’s asthma attack was questionably viral in 
etiology, one could argue that this infection was the nidus for the EDP episode; however, as 
testing for viral serology is not clinically indicated in such a setting, one could only speculate 
this potentially contributing.  Since our patient had a history of diarrhea, conceivably she may 
have always had DSP and developed enterovirus-associated eruptive pseudoangiomatosis (EP) in 
these areas that made the lesions manifest; however, we consider this much less likely based off 
the history, clinical and histopathological findings, and probability of having a rare disease like 
EP in conjunction with DSP. 
The mechanisms by which immunosuppression results in EDP are currently unclear.  In DSP, 
immunosuppression may trigger expression of a mutant clone of epidermal cells either directly 
or by disrupting the growth dynamics of the epidermis.  The cornoid lamella correlates with the 
border between normal epidermis and this clone of mutant keratinocytes.  Immune surveillance 
that might otherwise attack the mutant clone would be impaired in the setting of 
immunosuppression.10  We speculate immunosuppression caused by corticosteroids acts 
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similarly to cause the acute variant EDP, probably with other unknown pathways also 
contributing. 
After thorough literature review, we can affirm our case is indeed the second case of EDP most 
likely related to corticosteroid-induced immunosuppression.  Skin lesions of EDP in our patient 
have gradually improved after discontinuing oral steroid therapy with no other directly 
implemented therapy.  In summary, we describe a case of EDP following systemic corticosteroid 
therapy immunosuppression, which is only the second case described in the literature. 
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Learning Points 
• Eruptive disseminated porokeratosis (EDP) is a recently described and characterized form 
of porokeratosis involving the sudden onset of erythematous pruritic papules and plaques. 
• A high percentage of EDP cases occurred in the context of internal malignancy and 
immunosuppression. 
• Corticosteroid use can induce EDP. 
• EDP should alert the physician to strongly consider underlying immunosuppression and 
malignancies. 
• EDP may now be added as the sixth variant of the Porokeratoses. 
 
Learning objective:  To demonstrate knowledge of eruptive disseminated porokeratosis and risk 
factors surrounding it. 
1. Which of the following is characteristic only of eruptive disseminated porokeratosis 
(EDP) versus the more classic disseminated superficial (actinic) porokeratosis 
(DSP/DSAP)? 
a. Cornoid lamella 
b. Acute onset (weeks to months) 
c. Potentially underlying immunosuppression 
d. Monomorphic papules and plaques 
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e. Involvement of keratinocytes 
Answer to question 1 
a. Incorrect- Cornoid lamella is a histological feature of all porokeratoses. 
b. Correct- EDP is characterized by its acute onset (weeks to months), whereas the more 
classic DSP/DSAP has a chronic onset (develops over years). 
c. Incorrect- Both EDP and DSP/DSAP can develop in the context of immunosuppression 
d. Incorrect- Both EDP and DSP/DSAP typically manifest as these types of lesions 
e. Incorrect- expansion of an abnormal mutant clone of keratinocytes is thought to drive 
both processes 
 
2. Which health state has been suggested in the literature to induce EDP? 
a. High blood pressure 
b. Heart attack 
c. Underlying cancer/malignancy 
d. Tick bite 
e. Pregnancy 
Answer to question 2 
a. Incorrect- High blood pressure (hypertension) has not been previously reported or 
suggested to cause EDP. 
b. Incorrect- Heart attack/myocardial infarction has not been previously reported or 
suggested to cause EDP. 
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c. Correct- Underlying cancer/malignancy has been reported multiple times in the literature, 
and it is suggested that EDP may be a paraneoplastic syndrome of underlying 
malignancy. 
d. Incorrect- Tick bites and the diseases they can cause have not been previously reported or 
suggested to cause EDP. 
e. Incorrect- Pregnancy has not been previously reported or suggested to cause EDP. 
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Figure 1 
 
Eruptive disseminated actinic porokeratosis clinically manifesting as multiple erythematous, 
blanchable (illustrated above), well-defined papules and plaques with peripheral keratotic 
borders and atrophic centers on the lower extremities.  
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Figure 2 
 
Biopsy site on the left leg of a representative plaque illustrating the ridge-like border typical of 
porokeratosis lesions. 
  
Eruptive Disseminated Porokeratosis 
 
Figure 3 
    
a,b) Low and medium power showing follicular based angulated parakeratosis (cornoid lamella) 
with adjacent relatively atrophic epithelium (H&E 20X and 40X). c,d) Higher magnification 
showing dyskeratotic cells centered within follicles, angulated parakeratosis (cornoid lamella) 
and focal absence of granular cell layer diagnostic of porokeratosis (H&E 100X and 200X). 
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